{"DataElement":{"publicId":"3357643","version":"1","preferredName":"Cutaneous Melanoma American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for melanoma of the skin.","longName":"3357545v1.0:3357608v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3357545","version":"1","preferredName":"Cutaneous Melanoma Stage Grouping","preferredDefinition":"A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"2431290v1.0:2230143v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2431290","version":"1","preferredName":"Cutaneous Melanoma","preferredDefinition":"A malignant neoplasm derived from cells that are capable of forming melanin.","longName":"C3510","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma","conceptCode":"C3510","definition":"A primary melanoma arising from atypical melanocytes in the skin.  Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi.  Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF3BE-971D-3B79-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-65E7-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3357608","version":"1","preferredName":"Cutaneous Melanoma American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"A finding about one or more characteristics of cutaneous melanoma, following the rules of the TNM AJCC v7 classification system.  The TNM clinical and pathologic regional lymph nodes tumor classifications of cutaneous melanoma are not the same. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)_The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3357608v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Stage IV Skin Melanoma","ValueMeaning":{"publicId":"3357618","version":"1","preferredName":"Stage IV Skin Melanoma","longName":"3357618","preferredDefinition":"Stage IV includes: (Any T, Any N, M1).  M1: Distant metastasis. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Cutaneous Melanoma AJCC v6 and v7","conceptCode":"C9096","definition":"Stage IV includes: (Any T, Any N, M1).  M1: Distant metastasis. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6E27C0A-CE9A-C23B-E040-BB89AD430F5F","latestVersionIndicator":"Yes","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6E27C0A-CEB3-C23B-E040-BB89AD430F5F","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"ONEDATA","dateModified":"2012-01-19","deletedIndicator":"No"},{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6E27C0A-CE8D-C23B-E040-BB89AD430F5F","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"ONEDATA","dateModified":"2012-01-19","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Skin Melanoma","ValueMeaning":{"publicId":"3357620","version":"1","preferredName":"Stage III Skin Melanoma","longName":"3357620","preferredDefinition":"Stage III includes: Any T, N1-3, M0.  Stage III is divided into three pathologic subgroups: IIIA, IIIB, and IIIC.  There are no clinical subgroups for stage III.  N1: Cutaneous melanoma with metastasis in one regional lymph node.  N2: Cutaneous melanoma with metastases in 2-3 regional lymph nodes or in transit met(s)/satellite(s) without metastatic nodes.  N3: Cutaneous melanoma with 4 or more metastatic nodes, or matted nodes, or in transit met(s)/satellite(s) with metastatic node(s).  M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Cutaneous Melanoma AJCC v7","conceptCode":"C88415","definition":"Stage III includes: Any T, N1-3, M0.  Stage III is divided into three pathologic subgroups: IIIA, IIIB, and IIIC.  There are no clinical subgroups for stage III.  N1: Cutaneous melanoma with metastasis in one regional lymph node.  N2: Cutaneous melanoma with metastases in 2-3 regional lymph nodes or in transit met(s)/satellite(s) without metastatic nodes.  N3: Cutaneous melanoma with 4 or more metastatic nodes, or matted nodes, or in transit met(s)/satellite(s) with metastatic node(s).  M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6E27C0A-CEC0-C23B-E040-BB89AD430F5F","latestVersionIndicator":"Yes","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6E27C0A-CED9-C23B-E040-BB89AD430F5F","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"ONEDATA","dateModified":"2012-01-19","deletedIndicator":"No"},{"value":"IIC","valueDescription":"Stage IIC Skin Melanoma","ValueMeaning":{"publicId":"3357622","version":"1","preferredName":"Stage IIC Skin Melanoma","longName":"3357622","preferredDefinition":"Stage IIC includes: T4b, N0, M0.  T4b: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, with ulceration.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIC Cutaneous Melanoma AJCC v6 and v7","conceptCode":"C86034","definition":"Stage IIC includes: T4b, N0, M0.  T4b: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, with ulceration.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6E27C0A-CEE6-C23B-E040-BB89AD430F5F","latestVersionIndicator":"Yes","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6E27C0A-CEFF-C23B-E040-BB89AD430F5F","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"ONEDATA","dateModified":"2012-01-19","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Skin Melanoma","ValueMeaning":{"publicId":"3357624","version":"1","preferredName":"Stage IIB Skin Melanoma","longName":"3357624","preferredDefinition":"Stage IIB includes: (T3b, N0, M0); (T4a, N0, M0).  T3b: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, with ulceration.  T4a: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, without ulceration.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Cutaneous Melanoma AJCC v6 and v7","conceptCode":"C27742","definition":"Stage IIB includes: (T3b, N0, M0); (T4a, N0, M0).  T3b: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, with ulceration.  T4a: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, without ulceration.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6E27C0A-CF0C-C23B-E040-BB89AD430F5F","latestVersionIndicator":"Yes","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6E27C0A-CF25-C23B-E040-BB89AD430F5F","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"ONEDATA","dateModified":"2012-01-19","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Skin Melanoma","ValueMeaning":{"publicId":"3357626","version":"1","preferredName":"Stage IIA Skin Melanoma","longName":"3357626","preferredDefinition":"Stage IIA includes: (T2b, N0, M0); (T3a, N0, M0).  T2b: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, with ulceration.  T3a: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, without ulceration.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Cutaneous Melanoma AJCC v6 and v7","conceptCode":"C86033","definition":"Stage IIA includes: (T2b, N0, M0); (T3a, N0, M0).  T2b: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, with ulceration.  T3a: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, without ulceration.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6E27C0A-CF32-C23B-E040-BB89AD430F5F","latestVersionIndicator":"Yes","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6E27C0A-CF4B-C23B-E040-BB89AD430F5F","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"ONEDATA","dateModified":"2012-01-19","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Skin Melanoma","ValueMeaning":{"publicId":"3357628","version":"1","preferredName":"Stage IB Skin Melanoma","longName":"3357628","preferredDefinition":"Stage IB includes: (T1b, N0, M0); (T2a, N0, M0).  T1b: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, with ulceration or mitoses equal or more than 1/mm2. T2a: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, without ulceration.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Cutaneous Melanoma AJCC v7","conceptCode":"C86030","definition":"Stage IB includes: (T1b, N0, M0); (T2a, N0, M0).  T1b: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, with ulceration or mitoses equal or more than 1/mm2. T2a: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, without ulceration.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6E27C0A-CF58-C23B-E040-BB89AD430F5F","latestVersionIndicator":"Yes","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6E27C0A-CF71-C23B-E040-BB89AD430F5F","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"ONEDATA","dateModified":"2012-01-19","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA Skin Melanoma","ValueMeaning":{"publicId":"3357630","version":"1","preferredName":"Stage IA Skin Melanoma","longName":"3357630","preferredDefinition":"Stage IA includes: T1a, N0, M0.  T1a: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, without ulceration and with mitosis less than 1/mm2.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Cutaneous Melanoma AJCC v7","conceptCode":"C86026","definition":"Stage IA includes: T1a, N0, M0.  T1a: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, without ulceration and with mitosis less than 1/mm2.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6E27C0A-CF7E-C23B-E040-BB89AD430F5F","latestVersionIndicator":"Yes","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6E27C0A-CF97-C23B-E040-BB89AD430F5F","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"ONEDATA","dateModified":"2012-01-19","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Skin Melanoma","ValueMeaning":{"publicId":"3357762","version":"1","preferredName":"Stage 0 Skin Melanoma","longName":"3357762","preferredDefinition":"Stage 0 includes: Tis, N0, M0. Tis: Melanoma in situ. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.) ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Cutaneous Melanoma AJCC v6 and v7","conceptCode":"C8423","definition":"Stage 0 includes: Tis, N0, M0.  Tis: Melanoma in situ.  N0: No regional lymph node metastases.  M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6E3F2CD-0721-CF89-E040-BB89AD432510","latestVersionIndicator":"Yes","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"ONEDATA","dateModified":"2012-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6E3F2CD-0739-CF89-E040-BB89AD432510","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"ONEDATA","dateModified":"2012-01-19","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"Stage IIIC Skin Melanoma","ValueMeaning":{"publicId":"4382472","version":"1","preferredName":"Stage IIIC Skin Melanoma","longName":"4382472","preferredDefinition":"Stage IIIC includes: (T1-4b, N1b, M0); (T1-4b, N2b, M0); (T1-4b, N2c, M0); (Any T, N3, M0).  T1-4b: Ulcerated cutaneous melanoma of any thickness.  N1b: Cutaneous melanoma with macrometastasis in one regional lymph node.  N2b: Cutaneous melanoma with macrometastases in 2-3 regional lymph nodes.  N2c: Cutaneous melanoma with intralymphatic metastases (in transit or satellite metastases) without metastatic nodes.  N3: Cutaneous melanoma with 4 or more metastatic nodes, or matted nodes, or in transit met(s)/satellite(s) with metastatic node(s).  M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC Cutaneous Melanoma AJCC v7","conceptCode":"C86053","definition":"Stage IIIC includes: (T1-4b, N1b, M0); (T1-4b, N2b, M0); (T1-4b, N2c, M0); (Any T, N3, M0).  T1-4b: Ulcerated cutaneous melanoma of any thickness.  N1b: Cutaneous melanoma with macrometastasis in one regional lymph node.  N2b: Cutaneous melanoma with macrometastases in 2-3 regional lymph nodes.  N2c: Cutaneous melanoma with intralymphatic metastases (in transit or satellite metastases) without metastatic nodes.  N3: Cutaneous melanoma with 4 or more metastatic nodes, or matted nodes, or in transit met(s)/satellite(s) with metastatic node(s).  M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB4B974-F4F4-1715-E040-BB89AD431453","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB4B974-F50D-1715-E040-BB89AD431453","beginDate":"2014-07-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Skin Melanoma","ValueMeaning":{"publicId":"4382474","version":"1","preferredName":"Stage IIIB Skin Melanoma","longName":"4382474","preferredDefinition":"Stage IIIB includes: (T1-4b, N1a, M0); (T1-4b, N2a, M0); (T1-4a, N1b, M0); (T1-4a, N2b, M0); (T1-4a, N2c, M0).  T1-4b: Ulcerated cutaneous melanoma of any thickness.  T1-4a: Non-ulcerated cutaneous melanoma of any thickness.  N1a: Cutaneous melanoma with micrometastasis in one regional lymph node.  N2a: Cutaneous melanoma with micrometastases in 2-3 regional lymph nodes.  N1b: Cutaneous melanoma with macrometastasis in one regional lymph node.  N2b: Cutaneous melanoma with macrometastases in 2-3 regional lymph nodes.  N2c: Cutaneous melanoma with intralymphatic metastases (in transit or satellite metastases) without metastatic nodes.  M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Cutaneous Melanoma AJCC v7","conceptCode":"C86051","definition":"Stage IIIB includes: (T1-4b, N1a, M0); (T1-4b, N2a, M0); (T1-4a, N1b, M0); (T1-4a, N2b, M0); (T1-4a, N2c, M0).  T1-4b: Ulcerated cutaneous melanoma of any thickness.  T1-4a: Non-ulcerated cutaneous melanoma of any thickness.  N1a: Cutaneous melanoma with micrometastasis in one regional lymph node.  N2a: Cutaneous melanoma with micrometastases in 2-3 regional lymph nodes.  N1b: Cutaneous melanoma with macrometastasis in one regional lymph node.  N2b: Cutaneous melanoma with macrometastases in 2-3 regional lymph nodes.  N2c: Cutaneous melanoma with intralymphatic metastases (in transit or satellite metastases) without metastatic nodes.  M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB4B974-F51A-1715-E040-BB89AD431453","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB4B974-F533-1715-E040-BB89AD431453","beginDate":"2014-07-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Skin Melanoma","ValueMeaning":{"publicId":"4382476","version":"1","preferredName":"Stage IIIA Skin Melanoma","longName":"4382476","preferredDefinition":"Stage IIIA includes: (T1-4a, N1a, M0); (T1-4a, N2a, M0).  T1-4a: Non-ulcerated cutaneous melanoma of any thickness.  N1a: Cutaneous melanoma with micrometastasis in one regional lymph node.  N2a: Cutaneous melanoma with micrometastases in 2-3 regional lymph nodes.  M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Cutaneous Melanoma AJCC v7","conceptCode":"C86049","definition":"Stage IIIA includes: (T1-4a, N1a, M0); (T1-4a, N2a, M0).  T1-4a: Non-ulcerated cutaneous melanoma of any thickness.  N1a: Cutaneous melanoma with micrometastasis in one regional lymph node.  N2a: Cutaneous melanoma with micrometastases in 2-3 regional lymph nodes.  M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDB4B974-F540-1715-E040-BB89AD431453","latestVersionIndicator":"Yes","beginDate":"2014-07-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDB4B974-F559-1715-E040-BB89AD431453","beginDate":"2014-07-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3357607","version":"1","preferredName":"Cutaneous Melanoma TNM Finding v7 American Joint Committee on Cancer Stage Grouping Stage","preferredDefinition":"A finding about one or more characteristics of cutaneous melanoma, following the rules of the TNM AJCC v7 classification system.  The TNM clinical and pathologic regional lymph nodes tumor classifications of cutaneous melanoma are not the same. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR):The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C88378:C39315:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma TNM Finding v7","conceptCode":"C88378","definition":"A finding about one or more characteristics of cutaneous melanoma, following the rules of the TNM AJCC v7 classification system.  The TNM clinical and pathologic regional lymph nodes tumor classifications of cutaneous melanoma are not the same. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D97BB5-E891-8053-E040-BB89AD4336F4","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D97BB5-E8A2-8053-E040-BB89AD4336F4","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"COOPERM","dateModified":"2014-07-08","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12 Added 3 pathologic stage values per request by Duke. mc 7/8/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3434439","version":"1","longName":"Cutaneous Melanoma","context":"NCIP"},{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000347","version":"1","longName":"Cutaneous Melanoma","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"SWOG","type":"USED_BY","context":"SWOG"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"}],"ReferenceDocuments":[{"name":"Disease Stage","type":"Preferred Question Text","description":"Disease Stage","url":null,"context":"NCI Standards"},{"name":"Current Disease Stage","type":"Alternate Question Text","description":"Current Disease Stage","url":null,"context":"DCI"},{"name":"ECOG CRF Text 1","type":"Alternate Question Text","description":"Specify the classification","url":null,"context":"ECOG-ACRIN"},{"name":"Surgically resected AJCC stage","type":"Alternate Question Text","description":"Surgically resected AJCC stage","url":null,"context":"SWOG"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"B6E27C0A-D0C8-C23B-E040-BB89AD430F5F","latestVersionIndicator":"Yes","beginDate":"2012-01-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-19","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}